RISK HETEROGENEITY IN CLINICAL TRIALS: AN EVALUATION OF 25 LARGE CLINICAL TRIALS USING INDIVIDUAL PATIENT DATA

RISK HETEROGENEITY IN CLINICAL TRIALS: AN EVALUATION OF 25 LARGE CLINICAL TRIALS USING INDIVIDUAL PATIENT DATA

Bibliographic Details
Main Authors:	Kent, D, Nelson, J, Altman, D, Hayward, R
Format:	Journal article
Published:	2014

Similar Items

Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials
by: Kent, D, et al.
Published: (2016)

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.
by: Kent, D, et al.
Published: (2010)

Competing risk and heterogeneity of treatment effect in clinical trials
by: Alsheikh-Ali Alawi, et al.
Published: (2008-05-01)

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
by: Kent David M, et al.
Published: (2010-08-01)

Sharing individual patient data from clinical trials
by: Viraj Ramesh Suvarna
Published: (2015-01-01)

Allocation concealment in clinical trials.
by: Schulz, K, et al.
Published: (2002)

Towards agreement on best practice for publishing raw clinical trial data.
by: Hrynaszkiewicz, I, et al.
Published: (2009)

Data sharing in clinical trials: An experience with two large cancer screening trials.
by: Claire S Zhu, et al.
Published: (2017-05-01)

Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository
by: Tudur Smith, C, et al.
Published: (2014)

Monitoring of large randomised clinical trials: a new approach with Bayesian methods.
by: Parmar, M, et al.
Published: (2001)

Antihypertensive treatment and risk of cancer: individual participant data meta-analysis of randomized clinical trials
by: Narzarzedah, M, et al.
Published: (2021)

Clinical trials in pregnancy: evaluation of benefit/risk?
by: E. A. Sokova, et al.
Published: (2018-02-01)

Ethical issues in the reporting of clinical trials - Reply
by: Schulz, K, et al.
Published: (2001)

Reporting the clinical importance of randomized controlled trials.
by: Moher, D, et al.
Published: (2002)

Statistics notes: blinding in clinical trials and other studies.
by: Day, S, et al.
Published: (2000)

Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy
by: Emberson, J, et al.
Published: (2022)

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis
by: Kent David M, et al.
Published: (2006-04-01)

Are large clinical trials in orthopaedic trauma justified?
by: Sprague, S, et al.
Published: (2018)

Intent to share individual participant data of Indian clinical trials
by: Ronak Borana, et al.
Published: (2023-12-01)

Towards agreement on best practice for publishing raw clinical trial data
by: Altman Douglas G, et al.
Published: (2009-03-01)

Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.
by: Catrin Tudur Smith, et al.
Published: (2014-01-01)

Can randomised trials inform clinical decisions about individual patients?
by: Mant, D
Published: (1999)

The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
by: Helen Le Sueur, et al.
Published: (2020-06-01)

Optimising medication data collection in a large-scale clinical trial.
by: Jessica E Lockery, et al.
Published: (2019-01-01)

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
by: Helen Baldwin, et al.
Published: (2022-07-01)

Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
by: Baldwin, Helen, et al.
Published: (2023)

An evaluation of risk-based monitoring in pragmatic trials in UK Clinical Trials Units
by: Daniel Beever, et al.
Published: (2019-09-01)

Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials
by: Dwan, K, et al.
Published: (2014)

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.
by: Pocock, S, et al.
Published: (2002)

How large should a clinical trial be?
by: Pezeshk, H, et al.
Published: (2000)

Are large clinical trials in orthopaedic trauma justified?
by: Sheila Sprague, et al.
Published: (2018-04-01)

Systematic reviews in health care: Assessing the quality of controlled clinical trials.
by: Jüni, P, et al.
Published: (2001)

Reporting of clinical trials: a review of research funders' guidelines.
by: Dwan, K, et al.
Published: (2008)

Primed to comply: Individual participant data sharing statements on ClinicalTrials.gov.
by: Emily E Statham, et al.
Published: (2020-01-01)

SPIRIT 2013: new guidance for content of clinical trial protocols.
by: Chan, A, et al.
Published: (2013)

CRESTOR SHOWN SIGNIFICANT REDUCTION OF CARDIOVASCULAR RISK IN A LARGE CLINICAL TRIAL
by: статья Редакционная
Published: (2016-01-01)

CRESTOR SHOWN SIGNIFICANT REDUCTION OF CARDIOVASCULAR RISK IN A LARGE CLINICAL TRIAL
by: статья Редакционная
Published: (2016-01-01)

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.
by: Cooney, R, et al.
Published: (2007)

Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials - Comment
by: Altman, D
Published: (2005)

Clinical Trials: Minimising source data queries to streamline endpoint adjudication in a large multi-national trial
by: Ronald Elizabeth S, et al.
Published: (2011-05-01)